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Studies suggest the gut microbiota contributes to the development of obesity and the 46 
metabolic syndrome.  Exercise alters microbiota composition and diversity and is protective 47 
of these maladies. We tested whether the protective metabolic effects of exercise are 48 
mediated through fecal components through assessment of body composition and metabolism 49 
in recipients of fecal microbiota transplantation (FMT) from exercise-trained (ET) mice fed 50 
normal or high energy diets.  Donor C57BL/6J mice were fed a chow or high fat, high 51 
sucrose (HFHS) diet for 4wk to induce obesity and glucose intolerance. Mice were divided 52 
into sedentary (Sed) or ET groups [6wk treadmill-based ET] while maintaining their diets, 53 
resulting in four donor groups; chow sedentary (NC-Sed) or ET (NC-ET) and HFHS 54 
sedentary (HFHS-Sed) or ET (HFHS-ET).  Chow-fed recipient mice were gavaged with feces 55 
from the respective donor groups weekly, creating four groups (NC-Sed-R, NC-ET-R, 56 
HFHS-Sed-R, HFHS-ET-R) and body composition and metabolism assessed. The HFHS diet 57 
led to glucose intolerance and obesity in the donors, while exercise training (ET) restrained 58 
adiposity and improved glucose tolerance. No donor group FMT altered recipient body 59 
composition. Despite unaltered adiposity, glucose levels were disrupted when challenged in 60 
mice receiving feces from HFHS-fed donors, irrespective of donor-ET status, with a decrease 61 
in insulin-stimulated glucose clearance into white adipose tissue and large intestine and 62 
specific changes in the recipient’s microbiota composition observed. FMT can transmit 63 
HFHS-induced disrupted glucose metabolism to recipient mice independently of any change 64 
in adiposity. However, the protective metabolic effect of ET on glucose metabolism is not 65 
mediated through fecal factors.  66 
 67 
 68 





The gut microbiome is a large and sophisticated community of bacteria, fungi and archaea 71 
that reside within the gastrointestinal tract (GIT).  It has become clear that the composition of 72 
this community is associated with various pathological conditions. As this community plays a 73 
role in host metabolism, alterations to its membership, distribution or activity may impact 74 
metabolic-related disorders such as obesity, insulin resistance and type 2 diabetes (T2D) (13, 75 
21, 29, 32, 33, 41).  The microbiota state can be influenced by many factors, particularly host 76 
dietary composition and intake pattern.  Other environmental and lifestyle factors such as 77 
medication, exposure to pollutants, sleep and physical activity are also known microbiota 78 
modulators. Indeed, numerous studies in humans and animal models have reported 79 
microbiota changes upon exercise, and in athletes (2, 3, 5, 6, 10, 12, 20, 26, 27, 30, 34, 35, 80 
39). Yet, the precise beneficial or negative effects of exercise-induced microbiota alteration 81 
to the host remain largely unknown.  82 
 83 
Exercise training (ET) is widely accepted as a therapeutic intervention and protective against 84 
the development of obesity, insulin resistance and T2D (7). However, many individuals, 85 
especially the injured, frail and/or elderly, cannot exercise on a regular basis. Of those who 86 
can, rates of compliance are low. Therefore, identifying therapeutics that target pathways 87 
regulated by exercise and/or identifying modes of exercise giving maximal metabolic 88 
improvement are of interest. With exercise conferring many metabolic benefits through 89 
numerous mechanisms, it is unclear (and indeed difficult to discern) whether the microbiota 90 
is a conduit for such exercise-induced benefits. 91 
 92 
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Fecal microbiota transplantation (FMT) strives to engineer improvements in gut function 93 
and/or systemic health through the introduction of crude stool preparations from healthy 94 
donors. It has proven successful in treating chronic Clostridium difficile infections (40). 95 
Experimentally, FMT can reveal whether given effects are mediated through fecal 96 
components and are thusly transmittable. From a metabolic perspective, FMT has 97 
demonstrated some metabolism-related phenotypes to be fecal component-modulated in 98 
experimental models and human pilot trials, however the corresponding mechanistic 99 
foundations remain unknown (9, 23, 24, 37). FMT effects are rarely apportioned between 100 
fecal components of live cells, microbial cell components or metabolic factors of either 101 
microbe or host origin. The host is sensitive to all these components (36), and we postulate 102 
that any of them could exert a regulatory effect on metabolism.  103 
 104 
Here, we assessed whether the metabolic benefits exercise confers on the host are mediated 105 
through fecal factors.  Specifically, we assessed whether transfer of feces from exercise-106 
trained (ET) or sedentary donor mice, on either a normal or high caloric diet, alters 107 
microbiota composition, body composition and glucose metabolism in sedentary, normal 108 
chow-fed recipients. Our use of recipients on a chow diet was to provide the greatest 109 
opportunity for microbiota transfer to elicit an effect without the confounding factor of a 110 
microbiota-modulating high-energy diet in the recipients.  We hypothesized that recipients of 111 
FMT from high fat, high sucrose (HFHS)-fed, sedentary donor mice (HFHS-Sed) would have 112 
increased adiposity and disrupted glucose tolerance compared to mice receiving FMT from 113 
mice fed a chow diet. Further, we hypothesized that compared to mice that were sedentary, 114 
ET in the donors would protect the metabolic profile of recipients when they were 115 
transplanted with fecal matter from HFHS-fed mice. While the FMT was able to transmit 116 
HFHS-induced microbiota changes and disrupt glucose metabolism in recipient mice 117 
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independently of any change in adiposity, FMT from ET donor mice elicited no protective 118 
effect on glucose metabolism.      119 
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MATERIALS AND METHODS 120 
Animals 121 
C57BL/6J mice were sourced from Alfred Medical Research and Education Precinct 122 
(AMREP) Animal Services. All animals were fed a normal chow diet (NC) (14.0MJ/kg, 123 
75.2% kJ from carbohydrate, 4.8% from fat, 20% from protein: Specialty Feeds, WA, 124 
Australia) until they initiated the studies at 7-8 wk of age. Thereafter, depending on their 125 
allocated group, they were fed NC or a high fat, high sucrose diet (HFHS) (19MJ/kg, 36% kJ 126 
from carbohydrate (17% sucrose), 43% from fat 21% from protein; Specialty Feeds, WA, 127 
Australia) until study endpoint. The NC diet had a 5.2% total crude fibre composition and the 128 
HFHS diet 5.4%. Food and water access were unrestricted (except for experimental fasting 129 
periods). Mice were maintained at 22±1°C on a 12h light/dark cycle. The study was approved 130 
by the AMREP Animal Ethics Committee and conducted in accordance with National Health 131 
and Medical Research Council of Australia guidelines. Experimental procedure flowcharts 132 
(11) are provided in Figs 1-2. 133 
Study design 134 
The study involved both recipient and donor groups of male mice run in parallel (See Fig 3). 135 
Two cohorts were used to limit experimental burden per mouse and only one sex to remove 136 
the confounding physiological gender differences in this initial study. C57BL/6J mice were 137 
bred in two rounds, first producing pups for the donor groups and thereafter for recipient 138 
groups. At weaning, mice were re-housed across cages to remove cage-mate gut microbiome 139 
correlations (12) as a confounding factor. After 4 weeks of NC or HFHS diet (a time frame 140 
we have previously demonstrated induces full glucose intolerance and insulin resistance from 141 
HFHS diet (42)), donor mice commenced 6 weeks of treadmill running ET (or Sed control); 142 
NC or HFHS allocations were retained throughout. Four donor groups resulted: NC-143 
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Sedentary (NC-Sed), NC-Exercise-trained (NC-ET), HFHS-Sedentary (HFHS-Sed) and 144 
HFHS-Exercise-trained (HFHS-ET). At both initiation of diet and exercise interventions 145 
mouse body weights were analysed to exclude biases resulting from randomised group 146 
allocations (Fig 4A, E). Feces were collected from each donor mouse once weekly during the 147 
ET period for FMT.  148 
Recipient mice were NC-fed and sedentary. Groups were randomly assigned to receive FMT 149 
from each of the four donor groups: NC-Sedentary recipient (NC-Sed-R), NC-Exercise-150 
trained recipient (NC-ET-R), HFHS-Sedentary recipient (HFHS-Sed-R) and HFHS-exercise-151 
trained recipient (HFHS-ET-R). Recipient baseline body weight analysis discounted any 152 
randomisation-induced bias (Fig 4A). Mice were housed only with mice receiving the same 153 
treatment and received one gavage of fecal slurry per week for 6-weeks and metabolic 154 
parameters were assessed.   155 
Fecal Microbiota Transplantation (FMT) 156 
One freshly voided stool per donor mouse was collected each week and combined with other 157 
stools from the same group. Stool pellets were sliced with a scalpel and resuspended in 1ml 158 
phosphate-buffered saline (PBS) per stool. Stools were homogenised, then twice vortexed 159 
and incubated for 15-minutes at 370C, then vortexed again and spun at 800rpm for 3-minutes. 160 
The crude aqueous fecal extract was oral gavaged to recipients (200µl each) based on 161 
previous protocols (43). By performing weekly collections and gavages as the exercise 162 
training program progressed, we were attempting to simulate likely changes in the microbiota 163 
population over the course of a training program and transferring these to the recipients to 164 
assess any impact on metabolic read-outs.   165 
 166 




Exercise Capacity Test  168 
An acute incremental exercise test of donors was performed at commencement and 169 
completion of the ET intervention. Mice performed a 3-day familiarization protocol in which 170 
intensity and durations of treadmill running (Model Exer-3/6 Treadmill, Columbus 171 
Instruments, OH, USA) were progressively increased. The test began at 10m/min for 3 min. 172 
The velocity was increased by 4m/min every 3 min until fatigue. This was defined as 173 
spending >10 sec at the base of the treadmill despite manual encouragement.  174 
Exercise training  175 
Each session consisted of interval training, alternating 2 min of active running with 2 min of 176 
rest. Each session lasted for 60 min repeated 3 times per week. The initial speed was 177 
16.0m/min. Each week the speed was increased by 1m/min as progressive overload. 178 
Sedentary mice were removed from their holding room and their cages placed next to the 179 
treadmill for the duration of the running to control for the activity of removing them from 180 
their environment.  To control for any acute exercise effects, training was withheld for at 181 
least 48 h prior to glucose tolerance testing.  182 
Body composition analysis 183 
Fat mass and lean mass were measured with a 4-in-1 EchoMRI body composition analyzer 184 
(EchoMRITM, TX, USA) and standard laboratory scales were used for total body mass 185 
(Mettler Toledo, Greifensee, Switzerland) as previously described in full (28). 186 
Oral glucose tolerance test   187 
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Oral glucose tolerance tests (oGTT) were performed on fasted (6 h) mice. Mice received an 188 
oral gavage of 2g glucose/kg lean body mass (25% glucose solution) and blood glucose levels 189 
were measured via a glucometer (AccuCheck, NSW, Australia) at the indicated times on 190 
blood that was collected from the tail.  191 
Metabolic caging analysis (CLAMS) 192 
A Comprehensive Laboratory Animal Monitoring System (CLAMS, Columbus Instruments, 193 
OH, USA) was utilized to measure various aspects of metabolism as previously described 194 
(28). Mice were individually housed and oxygen consumption (VO2), respiratory exchange 195 
ratio (RER), Energy expenditure (heat) and total movement (beam breaks) were recorded 196 
over a 48 h period. The first 24hrs served as an acclimatisation period and the 24-48h period 197 
was analysed.   198 
In vivo intestinal permeability  199 
As a marker of gut permeability, a 500mg/kg bolus (125mg/ml) of Fluorescein 200 
isothiocyanate–conjugated dextran (FITC-labelled dextran, Sigma-Aldrich, MO, USA) was 201 
administered by oral gavage to fasting mice.  Blood was obtained from the tail into a 202 
heparinised capillary tube and plasma read on a fluorescent plate reader (Ex 490mm, Em 203 
520mm).  204 
Intravenous insulin tolerance test (ivITT) 205 
Intravenous insulin tolerance tests (ivITT) with combined glucose tracer were performed as 206 
previously described (17). Briefly, mice were anesthetized and their jugular vein cannulated. 207 
Following basal glucose measurements, a single bolus injection of insulin (0.6U/kg lean body 208 
mass) also containing [3H]2-deoxyglucose (10µCi) (PerkinElmer, MA, USA) was injected 209 
down the line. Blood was sampled at 0, 2, 5, 10, 20 and 30 min for determination of blood 210 
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glucose and 2, 10, 20 and 30 min for plasma radioactivity of [3H]2-DG. At endpoint, the 211 
organs were excised and snap frozen and stored at -80°C.  212 
 213 
Determination of plasma and tissue radioactivity  214 
The collected blood samples (10 µl) were deproteinized with barium hydroxide and zinc 215 
sulfate liquid scintillation fluid added and [3H]2-DG radioactivity determined. Accumulation 216 
of [3H]2-DG radioactivity in the tissue samples was determined by scintillation counting in 217 
an aqueous extract of the tissue after a homogenisation process. Free and phosphorylated 218 
[3H]2-DG were separated by ion exchange chromatography on Dowex 1-X8 columns. The 219 
area under the tracer disappearance curve for [3H]2-DG and the radioactivity for the 220 
phosphorylated [3H]2-DG from the organs were used to calculate the tissue-specific glucose 221 
clearance Kgʹ as previously described (8, 18). 222 
Fecal DNA extraction and sequencing 223 
DNA was extracted from the feces using a FastDNA Spin Kit for feces (MP Biomedicals, 224 
CA, USA) and sequencing conducted using a 16S V1-3 (27f/519r) amplicon on an Illumina 225 
MiSeq v3 at the Ramaciotti Centre for Genomics, Sydney, Australia.   226 
Microbial ecology profiling 227 
Microbial ecology analyses were performed using R; all analysis code is publicly available at 228 
https://github.com/marknormanread/henstridge-2019. Raw sequence reads were clustered 229 
into amplicon sequence variants (ASV) with inferred taxonomies using the ‘DADA2’ R 230 
package (4). Microbiota composition, alpha diversity, and sequencing depth analyses were 231 
performed with the ‘phyloseq’ R package (31). Alpha diversity and sequencing depth 232 
statistical comparisons were performed using PERMANOVA (‘adonis’ function from the 233 
‘vegan’ R package (19)). Rarefaction analysis was performed using custom code. Principal 234 
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component analyses (PCA) were performed using the ‘mixomics’ R package (38); data were 235 
transformed using the isometric logratio transformation. Isometric and centred logratio 236 
transformations reduce biases inherent in the compositional nature of microbial sequencing 237 
data (15). Microbes Bacteriodales S24-7 were renamed Bacteriodales Muribaculaceae in 238 
accordance with recent characterizations thereof (25). 239 
Statistical significance of microbiota clusterings by experimental group 240 
This analysis was performed with custom code. We employ the Aitchison metric (Euclidean 241 
distance between centred logratio transformed data) to calculate the pairwise distance 242 
between all samples. Thereafter, the distributions of within-group and between-group sample 243 
distances are contrasted using a one-sided Kolmogorov-Smirnov statistic; if the latter exceeds 244 
the former, then the groups have statistically significantly different microbiota compositions. 245 
P values were corrected for multiple comparisons using the Bonferroni method. 246 
Identifying microbial signatures through supervised machine learning 247 
Models were trained that predict experimental groups from microbiota profiles; the taxa 248 
employed by models form microbial signatures of experimental interventions. We employed 249 
the ‘leave-one-out’ cross validation (LOO-CV) methodology to build predictive models with 250 
square discriminant analysis (sPLS-DA), using the ‘mixomics’ R package (38). The available 251 
data is repeatedly partitioned into a ‘building’ portion used in model construction and a 252 
‘validation’ portion used to assess model performance. Under LOO-CV, each sample is 253 
retained as the sole validation portion member exactly once, with all remaining samples 254 
forming the building portion; hence, all available data are ultimately used (once) in assessing 255 
model performance. Model predictions of validation sample ‘class’ membership 256 
(experimental group) are through mahalanobis distance. Classification accuracies are reported 257 
for each class individually. Because the number of samples differs across experimental 258 
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groups, models were trained to minimise the balanced error rate (the mean average error rate 259 
across classes; each class is equally important regardless of size) rather than the overall error 260 
rate (% of total errors, biased towards larger classes). The error rate is 1-accuracy. Microbial 261 
ecology sequencing data is typically noisy and encompasses more numerous taxa than 262 
samples, which together risk spurious associations of taxa with experimental groups. Our 263 
methodology mitigates this risk by constructing models on the ‘building’ portions of repeated 264 
bifurcations of our data and uses these models to predict the experimental group of the 265 
withheld samples. The noise in building and validation portions differs and, hence, well-266 
performing microbial signatures likely represent genuine signal and not noise.  267 
The statistical significance of sPLS-DA model classification accuracy is estimated through 268 
permutation testing (reported in Supp Figure 4G). The available samples are randomly re-269 
assigned into classes of equal number and size as the real data. The sPLS-DA pipeline 270 
(including selecting sPLS-DA parameters for the maximum number of components 271 
investigated and the number of features to include in each component) is applied to the 272 
randomised data, and the most accurate result recorded.  This process is repeated 50 times. 273 
The estimated p value corresponds to the count of randomised accuracies surpassing that of 274 
the real data; 50 replicates yields a p value granularity of 0.02. Through this approach we 275 
gauge the potential for model overfitting – the likelihood that model accuracies reflect 276 
random chance or having identified sPLS-DA model parameters that serendipitously proffer 277 
superior performance despite the use of LOO-CV. This is an unavoidable when limited data 278 
are available and is evidenced by randomised data prediction accuracies greater than the e.g. 279 
50% that would be expected when employing two classes.  280 
The sPLS-DA ordinations show the two components capturing the most variance in the data; 281 
sPLS-DA models can include additional components (as indicated in figures). These 282 
ordinations represent the building of an sPLS-DA model on all available data using optimal 283 
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parameters as determined through LOO-CV. For taxa comprising signatures that distinguish 284 
experimental groups, we report only those taxa that were included in >90% of models built 285 
under LOO-CV; tables identifying employed in each sPLS-DA component are available at 286 
https://github.com/marknormanread/henstridge-2019. The experimental groups these taxa 287 
associate with are derived from the final model constructed over all available data (and 288 
reported in the ordinations).  289 
Biochemical Analysis  290 
Insulin: Insulin concentrations were measured with a mouse ultrasensitive Insulin ELISA 291 
(ALPCO Immunoassays, NH, USA). Plasma samples were read in a 96-well plate on a 292 
FLUOstar Omega microplate reader (BMG Labtech, VIC, Australia). Absorbance was 293 
measured at a wavelength of 450 nm. 294 
Lipopolysaccharide Binding Protein (LBP): LBP was measured via ELISA with the 295 
absorbance measured at 450nm with a spectrophotometer (Hycultec, Beutelsbach, Germany). 296 
Complete blood count. For hematological assessment, 20μL of whole blood was diluted 1:7 297 
in Sysmex CELLPACK™ (Sysmex, Japan) diluent and assessed using an automated 298 
hematology analyzer (Sysmex XS-1000i, Kobe, Japan). 299 
TAG Assay: Tissue TAG content was quantified using a colorimetric assay kit and calculated 300 
as µg/mg tissue (Triglycerides GPO-PAP; Roche Diagnostics, NSW, Australia). 301 
 302 
Statistical Analysis 303 
Metabolic data were analysed by three or two-way analysis of variance (ANOVA) and Tukey 304 
post-hoc tests when there was a significant interaction. All data are presented as mean ± 305 
standard error of the mean (SEM). Statistical significance was tested at p<0.05. Microbiota 306 
data was analysed as described above.   307 
  308 




Metabolic characteristics of donor mice. 310 
Donor mice were indistinguishable for body weight and lean mass at baseline (Fig 4A,C), 311 
however there was slightly less adiposity in the groups later designated for ET (Fig 4B, D). 312 
After 4 wk on their respective diets, the HFHS groups had greater body weight, fat mass and 313 
fat mass percentage and less lean mass compared with NC (Fig 4E-H). Relative to Sed, ET 314 
resulted in lower body weight, fat mass, lean mass and fat mass percentage (Fig 4I-L). ET led 315 
to improvements in exercise capacity on both diets, with mice on NC out-performing mice on 316 
the HFHS diet (Fig 5A). HFHS-fed mice exhibited higher daily caloric intake, but ET (vs 317 
Sed) proved inconsequential (Fig 5B). The HFHS diet caused glucose intolerance and ET 318 
countered it (Fig 5C), likely due to improved insulin sensitivity given there was no ET effect 319 
in basal or glucose-induced insulin secretion (Fig 5D,E). RER values were lower in mice fed 320 
a HFHS diet, but ET had no effect (Fig 5F). Summarily, the donor mice from which fecal 321 
material were collected for FMT displayed increased adiposity, glucose intolerance, caloric 322 
intake and hyperinsulinemia in the HFHS groups, with ET reducing adiposity and improving 323 
exercise capacity and decreasing glucose levels during an oGTT.   324 
FMT recipient mice do not display changes in body composition.  325 
Prior to commencing FMT, baseline body composition was assessed in the recipients with no 326 
difference observed for body weight, fat mass, lean mass or fat mass percentage (Fig 6A-D). 327 
The FMT treatment period had no effect on the recipients’ body composition with body 328 
weight, fat mass, lean mass and fat mass percentage not different between groups in the week 329 
of the last gavage (Fig 6E-H) or at the end of the study ~3wks later (Fig 6I-L). Consequently, 330 
any alteration in microbiota delivered to the recipients did not impact body composition and 331 
any subsequent effect was independent of adiposity. The potential exists for microbiota to 332 
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influence feeding behaviour (22) however, consistent with the body composition data, no 333 
change was detected in recipient intakes (Fig 7A). 334 
FMT recipient mice display higher glucose levels when challenged when treated with 335 
HFHS-donor microbiotas.  336 
Interestingly, despite the lack of an adiposity or food intake phenotype, mice administered 337 
FMT from HFHS donors, irrespective of donor ET status, had a spike in their blood glucose 338 
levels at early timepoints following an oGTT (Fig 7B), suggesting a defect in the ability to 339 
clear glucose or inhibit endogenous glucose production. Calculation of incremental AUC 340 
(iAUC) for the glucose curve demonstrated a significant increase in the mice receiving 341 
HFHS-FMT out to 90 minutes (Fig 7C) that was reduced to a trend by 120mins (p=0.081, Fig 342 
7D). As higher glucose levels could result from a pancreatic phenotype (if less insulin is 343 
secreted), we assessed basal and glucose-stimulated insulin secretion (15-minute) when the 344 
greatest difference in glucose was observed in the oGTT. There was no difference between 345 
the groups at either timepoint (Fig 7E,F). As insulin levels were unchanged, we next assessed 346 
whether there was a difference in insulin-stimulated glucose clearance into tissues. While we 347 
found no change in insulin-stimulated glucose clearance into skeletal muscle or brown 348 
adipose tissue (Fig 7G, H), we did detect a decrease in glucose clearance into epididymal 349 
white adipose tissue (WAT) in recipients of FMT from HFHS-donors (Fig 7I). We also 350 
assessed sections of the GIT, relevant given FMT, finding a decrease in the glucose clearance 351 
into the large but not small intestine under HFHS-donation (Fig 7J,K). 352 
Glucose tolerance defect in HFHS-R mice is not due to lipid accumulation, physical 353 
activity or energy expenditure. 354 
Given the alteration to glucose levels during the oGTT in the HFHS recipient mice, we 355 
assessed possible mechanisms of action. Despite no difference in adiposity, it is possible that 356 
Downloaded from journals.physiology.org/journal/ajpendo at Monash Medical Centre (130.194.020.173) on June 9, 2020.
17 
 
there had been alterations to the partitioning of lipids within organs which can disrupt glucose 357 
metabolism. We assessed triacylglyceride levels in the large intestine and WAT (locations of 358 
insulin-stimulated glucose clearance defects), but found no difference between recipient 359 
groups (Fig 7L,M). As hepatic steatosis is linked to disrupted glucose handling (42), we also 360 
measured triacylglyceride levels in the liver, but again observed no difference (Fig 7N).  361 
It is possible that alterations to physical activity, substrate utilisation or energy expenditure 362 
could drive a change in glucose disposal before such changes manifest in the body 363 
composition data. Indirect calorimetry studies could not detect a difference in oxygen 364 
consumption, energy expenditure or physical activity levels between the groups (Fig 365 
8A,B,D). There was a decrease in the RER in the NC-Ex-R group (Fig 8C), suggesting a 366 
preference towards fatty acid utilisation, however, we reiterate, a decrease in triacylglyceride 367 
content was not evident in the three tissues we assessed (Fig 7J-L). This finding of a decrease 368 
in RER in the NC-Ex-R group was independent of donor RER given there was not a 369 
difference in donor RER with exercise on the NC diet (Fig 5F).  370 
Glucose tolerance defect in HFHS-R mice is not due to leaky gut, or changes to blood 371 
profile or inflammation. 372 
A well characterized mechanism of diet-induced change in host-microbiota interaction is the 373 
inflammophile positive feedback loop, wherein microbes capable of anaerobic growth on 374 
inflammatory factors promote inflammation to gain a competitive ecological advantage (16). 375 
To assess this, we measured gut permeability and lipopolysaccharide-binding protein (LBP), 376 
an acute phase protein produced by the liver that recognises lipopolysaccharide. We detected 377 
no difference between recipient groups under either measure (Fig 8E,F). Finally, we 378 
conducted a complete blood count to determine any effect of the FMT on circulating cells. 379 
White blood cells, platelets and red blood cells were all unchanged in the recipients (Fig 8G).  380 
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The microbiotas of HFHS-R mice are distinguishable from NC-R mice with limited effect 381 
of ET status.  382 
We next profiled the gut microbiotas of recipient mice via fecal 16S ribosomal RNA 383 
sequencing before and after their FMT, confirming that each donor intervention induced 384 
distinct and transmissible microbial communities, and seeking a potential explanation for the 385 
elevated glucose during the oGTT. Recipient mice microbiotas were dominated with 386 
members of the Bacteriodetes and Firmicutes phyla, (Fig 9A,B). We discounted insufficient 387 
or differential sequencing depth as confounding factors for subsequent analysis (Fig 9C,D). 388 
As expected, pre-FMT microbiotas exhibited no clustering by experimental group, (Fig 9E). 389 
However, post-FMT microbiotas did cluster by donor diet, but not donor exercise state (Figs 390 
9F, Fig 10A,B). Microbiota ecological diversities also differed with donor diet (Fig 10C); 391 
diversity was higher in recipients of NC-donors, and highest in the NC-ET-R group. In 392 
summary, donor diet explained much of the variation between samples and lead to less 393 
diverse microbiota communities in the HFHS-recipients; this was not so for donor exercise 394 
state.  395 
Next, we sought signatures, comprising subsets of taxa, in recipient microbiotas that were 396 
distinguishing of donor diets and exercise states through supervised machine learning (Fig 397 
10D). We derived a model representing signatures correctly indicative of sample donor group 398 
(NC-Sed, NC-ET, HF-Sed, HF-ET) on average 80% of the time (Fig 10E). For context, as a 399 
baseline, ‘guessing’ the majority group for all samples would yield an accuracy of 29% 400 
(majority group is HF-Ex, representing 10 of the total 34 samples). We sought to explicitly 401 
test and discount model overfitting as a driver of accuracy; the attained 80% exceeded all 50 402 
applications of an identical methodology to random experimental group reassignments 403 
amongst these samples, indicating p<0.02 (Fig 11). The model was relatively complex, 404 
encompassing 35 unique amplicon sequence variants (ASVs) to distinguish the 4 groups 405 
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(Supp Table 1). Interestingly, distinct strains of identical phylotypic classification associated 406 
with multiple experimental groups, suggesting strain-level functional differences. Examples 407 
include strains classifying as Erysipelotrichaceae Allobaculum, Bacteroidales 408 
Muribaculaceae and Lachnospiraceae. 409 
Microbial signatures reliably indicative of donor diet, irrespective of donor exercise-state, 410 
were also derived (Figs 10F, 11, Supp Table 2). ASV classifying as Erysipelotrichaceae 411 
Allobaculum and Bacteroidales Muribaculaceae were over-represented in FMT recipients of 412 
NC-fed donor. Interestingly, other ASV also classifying as Bacteroidales Muribaculaceae 413 
were over-represented in the HFHS-R, further suggesting strain-level functional differences. 414 
ASVs classifying as Cyanobacteria 4C0d-2 YS2 were likewise over-represented in HFHS-R, 415 
as was a Lachnospiraceae of undetermined genus.  416 
Whilst we found experimental groups receiving ET and Sed FMT on the same diet to be 417 
statistically indistinguishable at the whole microbiota-level (Fig 10C), machine learning does 418 
identify microbial signatures indicative of donor exercise state (Figs 10D,G, 11, Supp Table 419 
3), though not as robustly as for donor diet (Fig 10F). Associated with the FMT of sedentary 420 
donors were ASV classifying as: Lactobacillaceae lactobacillus, Alcaligenaceae sutterella, 421 
Bacteroidales Muribaculaceae (genus undetermined), Prevotellaceae prevotella, 422 
Lachnospiraceae (genus undetermined). Associating exercised donors were ASV classifying 423 
as: Alphaproteobacteria RF32 (genus undetermined), other Bacteroidales Muribaculaceae 424 
(genus undetermined), Porphyromonadaceae parabacteroides. 425 
 426 
  427 




Altered gut microbiota composition has emerged as a component of the ET state. Indeed, 429 
recent studies even suggest that FMT could be used to increase endurance exercise 430 
performance (39). The precise role these changes have on host metabolism are largely 431 
unknown and are difficult to characterize given the multiple mechanisms through which 432 
exercise alters metabolic processes. Whether these changes are metabolically protective in an 433 
environment of over-nutrition is of interest, given the worldwide need to offset the growing 434 
incidence of obesity, insulin resistance and T2D. Through FMT, we investigated if exercise 435 
conferred microbiota-mediated effects of metabolic value to the host. While we confirm in 436 
non-germ-free, non-antibiotic treated mice that FMT from HFHS-fed donors is, at least in 437 
part, capable of negatively impacting recipient glucose levels during an oGTT, we find no 438 
evidence that FMT from ET donors alters recipients’ metabolic profile. 439 
Transfer of gut microbiota to recipient mice caused a glucose spike during an oGTT if the 440 
donor was fed a HFHS-diet, independently of donor exercise status. To put the magnitude of 441 
the effect into perspective, the average oGTT blood glucose difference at the 15 min mark 442 
between the NC-Sed and HFHS-Sed donor groups was 3.78mmol/L (Fig 5C). The difference 443 
at the same 15 min mark between FMT recipients of NC-Sed and HFHS-Sed was 444 
2.81mmol/L (Fig 7B). Hence, contrasted with mice fed a HFHS diet for ~2months, simple 445 
FMT from these animals into NC-fed recipients transfers over 70% of the early glucose level 446 
defect. This finding is of interest given: 1) the recipient mice experienced no increase in 447 
adiposity, so it was not an adipose-driven phenomenon, 2) it was independent of a leaky gut-448 
inflammatory environment and 3) the HFHS-Ex-R group phenocopied the HFHS-Sed-R 449 
group meaning that donors being exercised, having reduced adiposity and improved glucose 450 
levels during an oGTT, conferred no protective effect. This suggests that the “Fat but Fit 451 
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paradox” may not extend to the gut microbiota and associated host glucose metabolism 452 
regulation.  453 
An important factor in identifying host-microbe metabolic interactions is exposure timing.  454 
Foley and colleagues (14) demonstrated that mice exposed to feces from soiled cages from 455 
high fat-fed mice in the short-term (4 days) had similar glucose tolerance as compared to 456 
mice exposed to feces from chow-fed mice.  However, after longer-term (45 days) of 457 
microbiota exposure, mice that were exposed to feces from high fat-fed mice were more 458 
glucose intolerant compared to mice that received feces from chow-fed mice. Importantly, 459 
this is the same timeframe in which we assessed glucose control in our study. Given that this 460 
length of exposure time was significant enough to promote dysglycemia in both these studies 461 
in response to high energy-diet FMT/fecal exposure, we believe it is also long enough for any 462 
exercise-induced effects to manifest, though we cannot exclude that longer exposure time to 463 
the exercise-trained microbiota may be necessary to see an impact on glycemia.     464 
One metabolic parameter that was assessed whereby there was an exercise effect on the 465 
recipients was the RER values for the NC-ET-R group which showed lower values compared 466 
to the NC-Sed-R group (Fig 8C). A lower RER is indicative of a drive towards fatty acid 467 
utilisation/oxidation and linked to endurance training due to mitochondrial enzyme 468 
adaptations. However, in our hands we saw no difference with exercise training in the donors 469 
in relation to RER (Fig 5F. Consequently, it wasn’t the case of a direct effect of the NC-ET 470 
donors having a lower RER and transmitting that to the recipients and must have arisen due 471 
to more complicated mechanisms.  While we saw no effect on TAG levels in the large 472 
intestine, WAT or liver of the NC-ET-R group, we cannot exclude the possibility that there 473 
were lipid alterations in other organs. The effect was only observed in the NC groups 474 
suggesting that its transmission was nullified when the donors were fed a HFHS-diet.  Future 475 
studies designed to specifically elaborate on this finding may be warranted.      476 
Downloaded from journals.physiology.org/journal/ajpendo at Monash Medical Centre (130.194.020.173) on June 9, 2020.
22 
 
Our data also demonstrate that diet asserts dominance over physical activity in relation to gut 477 
microbial composition and penetrance of recipient metabolic phenotypes with FMT. In 478 
untargeted analyses recipient microbiotas readily clustered by donor diet but donor exercise 479 
state was indistinguishable. Whilst targeted supervised machine learning did identify subsets 480 
of microbes that reliably identified exercise status, the models were more nuanced and 481 
encompassed a greater number of microbes than when distinguishing donor diet. This 482 
suggests that donor diet was readily determinable through few microbes, but exercise induced 483 
far more subtle patterns spanning multiple microbes.  484 
During the preparation of this manuscript a paper was published (26) whereby the authors 485 
performed a similar set of experiments. In their study, administration of FMT from ET mice 486 
to antibiotic-treated high fat-fed recipient mice (5 FMT’s/wk for 12 wk) decreased adiposity 487 
and blood glucose levels in the recipients (26). While this previous study suggested exercise 488 
conferred some microbiome-mediated effects, they were predicated on a fairly extreme 489 
protocol of treatment of antibiotics and many gavages. Our study suggests that such effects 490 
would be relatively minor under more realistically tempered contexts of people adhering to 491 
regular physical activity. The discordant results of their study with our own likely stem from 492 
methodological differences. The current study used NC recipients while the previous study 493 
used high fat-fed (60% fat) recipients. We avoided antibiotic pre-treatment whereas their 494 
mice received ciprofloxacin/metronidazole. The present study used 6 FMT’s where the other 495 
study performed 60.   Also, we utilised a sham gavage control group (NC-Sed donors  NC-496 
Sed recipients) to control for 1) the stress of gavage treatment and for any potential metabolic 497 
impact of this and 2) introducing new microbial constituents to the gut; conversely, the 498 
control group in the other paper was treatment naïve (26). It would be interesting in future 499 
studies to combine their approach with our method. That is, to test the effect of FMT from ET 500 
donors on high-fat-fed recipients but at less frequency, with the inclusion of a gavage control 501 
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group and with and without antibiotic treatment. Another additional experimental design may 502 
be to test if precolonization of recipient mice with microbes from ET-donor mice could 503 
protect against the effects of later, subsequent exposure of FMT from HFHS-fed mice.  504 
 505 
The specific composition of high caloric diet may also limit whether exercised microbiota is 506 
transmissible and/or metabolically protective as microbiota transmissibility has been 507 
previously shown to be non-effective when recipients are fed a diet high in fat (37). 508 
Consequently, looking at our study and other similar studies, the pathological or 509 
physiological metabolic state of the recipient may be an important determining factor in the 510 
effectiveness of FMT or the ability of FMT to assert a phenotype. This is an important factor 511 
for scientists to consider when conducting such studies.   512 
 513 
Our study has some limitations worthy of consideration. Despite investigating numerous 514 
potential mechanisms via which the FMT from HFHS-donors may be causing the glucose 515 
spike during the oGTT in recipients (i.e. blood cell profile, leaky gut, lipid accumulation, 516 
inflammation, microbiota composition) we cannot provide a precise mechanism of action. 517 
Other mechanistic candidates for the effect include, but are not limited to, tissue cross-talk 518 
signalling, neural regulation, alteration to blood flow and glucose transport regulation. 519 
Additionally, as our oGTTs did not contain glucose stable isotope tracers we could not 520 
determine the relative contribution of the liver to the glucose spike phenotype. The study 521 
assessed only one method of delivering the FMT (orally). It is possible that rectal FMT may 522 
have yielded a different profile of viable microbes colonising the gut, and thus a differing 523 
metabolic phenotype. We also cannot conclude whether the observed effects were due to the 524 
microbiota changes or other fecal-derived components that were transferred, or whether the 525 
effects require microbial engraftment, as gavages were administered periodically throughout. 526 
Downloaded from journals.physiology.org/journal/ajpendo at Monash Medical Centre (130.194.020.173) on June 9, 2020.
24 
 
Determining the ratio of alive/dead bacteria that is transplanted with FMT in future studies 527 
may provide information in determining factors impacting on glucose metabolism following 528 
FMT. Further, completely recolonising the gut with FMT (i.e. like what occurs with the use 529 
of germ-free mice or broad-spectrum antibiotic treatment) may have yielded different results. 530 
Such procedures may promote the engraftment of microbes during and following on from the 531 
FMT process, when the intestine is devoid of microbiota and consequently the competition 532 
for engraftment and growth is lowered. We selected our approach to test our hypothesis with 533 
mice in their natural state to simulate as closely as possible the normal physiological system 534 
(i.e. a system where we tested FMT efficacy in mice that already harboured a natural 535 
microbiota composition; this would better reflect the microbiota of people commencing an 536 
exercise regime with diet-induced microbiota in place).  537 
 538 
Together, our study demonstrates that the negative effects of HFHS-diet on glucose levels 539 
during an oGTT can be transferred to recipient mice via FMT. This may be an important 540 
factor to consider when screening donors for FMT. Indeed, there are case reports of potential 541 
transmission of new-onset obesity via FMT (1), so donor-metabolic screening may need 542 
prioritisation to protect the metabolic health of recipients. Our study also questions whether 543 
ET-induced changes in microbiota composition can dominate over normal diet-influenced 544 
composition to an extent to alter host metabolism as besides an alteration to RER (on normal 545 
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Fig 1: Flow diagram of animal use and analysis for the donor groups based on the 713 
Consolidated Standards or Animal Experiment ReporTing (CONSAERT) template. 714 
 715 
Fig 2: Flow diagram of animal use and analysis for the recipient groups based on the 716 
Consolidated Standards or Animal Experiment ReporTing (CONSAERT) template. 717 
 718 
Fig 3: Study design for donor and recipient groups.  719 
 720 
Fig 4. Body composition analysis in fecal donor cohort. A-D) Body weight, fat mass, lean 721 
mass and body fat percentage at baseline (7-8 wk of age), following 4 wk of dietary 722 
intervention (pre-exercise) (E-H) and following ET intervention (I-L). NC-Sed n =17, NC-ET 723 
n=20, HFHS-Sed n=17, HFHS-ET n=21. 2-way ANOVA. ** p = <0.01, *** p = <0.001 for 724 
dietary main effect, # p =<0.05, ## p = <0.01, ### p = <0.001 for ET main effect. 725 
 726 
Fig 5. A) Exercise capacity from an incremental exercise test pre and post training, NC-ET 727 
pre and post n =11, HFHS-ET pre and post n = 10. B) Caloric intake per day during training 728 
period (measured and averaged per 24 h over 4 days, n =4) C) Glucose excursions from an 729 
oral glucose tolerance test (oGTT), NC-Sed n= 9, NC-ET n=11, HFHS-Sed n=10, HFHS-ET 730 
n=10. D,E) Plasma insulin levels at baseline and 15 min into the oGTT, NC-Sed n=9, NC-ET 731 
n=11, HFHS-Sed n=10, HFHS-ET n=10. F) RER of donor cohorts as measured in metabolic 732 
caging experiments. n=6 per group.  2-way ANOVA. * p = <0.05, *** p = <0.001 for dietary 733 
main effect, # p =<0.05, ## p = <0.01, ### p = <0.001 for ET main effect.  734 




Fig 6. Body composition of FMT recipient mice. A-D) Body weight, fat mass, lean mass and 736 
body fat percentage at baseline (7-8wks of age), following 6wks of weekly FMT intervention 737 
(E-H) and at endpoint of study ~3wk after last gavage (I-L). NC-Sed-R n =13, NC-ET-R 738 
n=15, HFHS-Sed-R n=14, HFHS-ET-R n=16.  739 
 740 
Fig 7. Metabolic characteristics of FMT recipient mice. A) Food intake per day during 741 
gavage period (measured and averaged per 24 h over 4 days, n=4. B) Plasma glucose 742 
excursion curves from an oral glucose tolerance test, NC-Sed-R n =13, NC-ET-R n=15, 743 
HFHS-Sed-R n=14, HFHS-ET-R n=16. C-D) Incremental area under the glucose curve 744 
analysis, NC-Sed-R n =13, NC-ET-R n=15, HFHS-Sed-R n=14, HFHS-ET-R n=16. E-F) 745 
Plasma insulin concentration before and during the oral glucose tolerance test, NC-Sed-R n 746 
=7, NC-ET-R n=9, HFHS-Sed-R n=8, HFHS-ET-R n=10. G-K) Insulin-stimulated glucose 747 
clearance into G) skeletal muscle, H) brown adipose tissue (BAT), I) white adipose tissue 748 
(WAT), J) large intestine, K) small intestine, NC-Sed-R n =7, NC-ET-R n=9, HFHS-Sed-R 749 
n=8, HFHS-ET-R n=6. Triacylglyceride levels in L) large intestine, NC-Sed-R n =7, NC-ET-750 
R n=9, HFHS-Sed-R n=8, HFHS-ET-R n=6, M) white adipose tissue, NC-Sed-R n =5, NC-751 
ET-R n=5, HFHS-Sed-R n=4, HFHS-ET-R n=6, and N) liver, NC-Sed-R n =7, NC-ET-R 752 
n=9, HFHS-Sed-R n=8, HFHS-ET-R n=6. 3 or 2-way ANOVA. * p = <0.05, ** p = <0.01 for 753 
diet effect.  754 
 755 
Fig 8. Metabolic measures in FMT recipient mice. A) VO
2, 
B) Energy expenditure, C) 756 
Respiratory exchange ratio (RER) and D) physical activity levels from metabolic caging 757 
experiments, n=6/group. E) Plasma FITC-dextran measurement as a measure of gut 758 
permeability, NC-Sed-R n=5, NC-ET-R n=3, HFHS-Sed-R n=5, HFHS-ET-R n=6. F) Plasma 759 
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LBP concentration as a marker of systemic inflammation, NC-Sed-R n =8, NC-ET-R n=10, 760 
HFHS-Sed-R n=10, HFHS-ET-R n=12.  Plasma analysis in FMT recipient mice. G) Total 761 
white blood cells, platelets and red blood cell counts. n=6/group. 2-way ANOVA with tukey 762 
post-hoc for interaction (when between 2 bars). # p = <0.05, ### p = <0.001 for ET effect. ** 763 
p = <0.01, ***p=<0.001 for diet effect.  764 
 765 
Fig 9. Fecal gut microbiota composition in recipient mice post-FMT. Microbiota composition 766 
of recipients at the A) phylum and B) family levels, based on bacterial 16S rRNA 767 
sequencing. C) Number of sequence reads per sample, collected by donor group. D) 768 
Rarefaction curves quantifying distinct microbes (amplicon sequence variants, ASV) 769 
identified when subsampling the available data; sequencing effort adequately captured the 770 
diversity of microbes present. Principal component analysis ordinations showing recipient 771 
microbiota similarities of recipients E) at baseline (pre-FMT) and F) following gavage 772 
treatment study conclusion. NC-Sed-R n =7, NC-ET-R n=9, HFHS-Sed-R n=8, HFHS-ET-R 773 
n=10.    774 
 775 
Fig 10: Donor diets drive community-level differences in recipient microbiota, but both 776 
donor diet and exercise statuses induce distinguishing microbial signatures in subsets of taxa. 777 
A) Assessing the clustering of microbiotas by donor group by contrasting between- versus 778 
within-group Aitchison distances; distance distributions shown in B. C) Microbiota alpha 779 
diversity quantifications: the number of distinct amplicon sequence variants observed, 780 
Shannon and Inverse Simpson metrics. Black circles indicate mean values. * p = <0.05, ** p 781 
= <0.01, *** p = <0.001 for dietary effect; no ET effects found; assessed through 782 
PERMANOVA. D) We assess whether donor experimental statuses induce distinguishing 783 
alterations across subsets of recipient microbiota taxa (‘signatures’) through supervised 784 
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machine learning (sparse partial least squares discriminant analysis, sPLS-DA). Such 785 
signatures can emerge even in absence of significant whole-community-level effects, as for 786 
ET status. E-G) sPLS-DA models are constructed to distinguish recipients’ microbiotas based 787 
on E) donor diets and ET states, F) diets irrespective of exercise state and G) exercise states 788 
irrespective of diet. NC-Sed-R n =7, NC-ET-R n=9, HFHS-Sed-R n=8, HFHS-ET-R n=10.    789 
 790 
Fig 11: Microbial signatures derived through sPLS-DA were robust and not the result of 791 
models overfitting to noise in the data, determined through repeated model re-training under 792 
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Animals ordered/issued: (n=75) Sex: (M/F) (75/0)






*6 of the mice in the HFHS-Ex group had  a modified training program in some sessions in week 6 of the training due to inability









*1 mouse in HFHS-Ex group had a modified training program is some sessions in week 6 of the training.
FIG 1
Donor Mice
Cohort 1: (n=40) Cohort 2: (n=35) 
Excluded: (n=0) 
Randomized: (n=35) No structured method 
Allocated to (AT) HFHS (n=18)
Received intervention (RI): (n=18)
Did not receive intervention (DNRI) : (n=0)
Allocated to (AT) NC: (n=17)
Received intervention (RI) : (n=17)




Allocated to (AT) NC: (n=20)
Received intervention (RI): (n=20)
Did not receive intervention (DNRI): (n=0)
Allocated to (AT) HFHS: (n=20)
Received intervention (RI): (n=20)























Tested in oGTT: (n=9-11)
Data not reported: (n=0)
Included in publication: n= 9-11
Exercise Capacity: (n=10-11)
Data not reported: (n=0)
Included in publication: n= 10-11
Food Intake: (n=9-11 
averaged/day) for 4-days
Data not reported: (n=0)
Included in publication: n= 4 days
Stool Collection for FMT: (n=9-11)
Stools not used: (n=0)
Included in FMT: n= 9-11
Body Composition Analysis (n=17-21)
NC-Sed: (n=17), NC-Ex (n=20), HFHS-Sed: (n=17), HFHS-Ex: (n=21)
Data not reported: (n=0)
Included in publication: n= 17-21
Stool Collection for FMT: (n=7-11)
Stools not used: (n=0)
Included in FMT: n= 7-11
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Animals ordered/issued: (n=58) Sex: (M/F) (58/0)










Tested in ivITT: (n=7-10 / group)
Data not reported: (n=4)
Reason: *Four mice died during the surgical procedure and 
did not complete the testing. All from HFHS-Ex-R group.
Included in publication: n= 6-9
FIG 2
Recipient Mice
Cohort 1: (n=34) Cohort 2: (n=24) 
Excluded: (n=0) 
Randomized: (n=24) No structured method 
Allocated to (AT) HFHS (n=12)
Received intervention (RI): (n=12)
Did not receive intervention (DNRI) : (n=0)
Allocated to (AT) NC: (n=12)
Received intervention (RI) : (n=12)




Allocated to (AT) NC: (n=16)
Received intervention (RI): (n=16)
Did not receive intervention (DNRI): (n=0)
Allocated to (AT) HFHS: (n=18)
Received intervention (RI): (n=18)










Randomized: (n=16) No structured method Randomized: (n=18) No structured method Randomized: (n=12) No structured method Randomized: (n=12) No structured method 













Body Composition Analysis (n=13-16)
NC-Sed: (n=13), NC-Ex (n=15), HFHS-Sed: (n=14), HFHS-Ex: (n=16)
Data not reported: (n=0)
Included in publication: n= 13-16
Tested in oGTT: (n=13-16)
Data not reported: (n=0)
Included in publication: n= 13-16
Insulin from oGTT: (n=7-10)
Data not reported: (n=0)
Included in publication: n= 7-10
Microbiota analysis: (n=7-10/group)
Data not reported:  (n=0)
Included in publication: n= 7-10
FITC-dextran: (n=6/group -24 samples)
Data not reported: 5 samples as they were 
not within the limit of detection of plate-reader.
Included in publication: (n=3-6)
CLAMs testing: (n=6/group)
Data not reported:  (n=0)
Included in publication: n= 6
Procedures/
Analysis
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